Bispecific Antibodies for Follicular Lymphoma - Episode 8

Advent of Bispecific Antibodies for Relapsed/Refractory Follicular Lymphoma

,

Expert perspectives on the advent of bispecific antibody therapy in relapsed/refractory follicular lymphoma, centered on data and experience with several novel agents.

EP. 1: An Overview on the Nature of Follicular Lymphoma
EP. 2: Follicular Lymphoma Workup: Risk Stratification and Staging
EP. 3: Follicular Lymphoma Workup: What is the Role of PET Imaging?
EP. 4: First-Line Treatment Strategies in Follicular Lymphoma
EP. 5: Relapsed/Refractory Follicular Lymphoma: Second-Line Treatment Armamentarium
EP. 6: Novel Targeted Agents in Multiply Relapsed Follicular Lymphoma
EP. 7: Multiply Relapsed Follicular Lymphoma: Overview on CAR T-Cell Therapy
Now Viewing
EP. 8: Advent of Bispecific Antibodies for Relapsed/Refractory Follicular Lymphoma
EP. 9: Bispecific Antibodies in Relapsed/Refractory Follicular Lymphoma: AE Management
EP. 10: Follicular Lymphoma: Forecasting Bispecific Antibody Treatment Strategies